5-147831719-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003122.5(SPINK1):c.-142T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,516,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
SPINK1
NM_003122.5 5_prime_UTR
NM_003122.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.42
Genes affected
SPINK1 (HGNC:11244): (serine peptidase inhibitor Kazal type 1) The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BS2
High AC in GnomAd4 at 24 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPINK1 | NM_001379610.1 | c.-142T>C | upstream_gene_variant | ENST00000296695.10 | NP_001366539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPINK1 | ENST00000296695.10 | c.-142T>C | upstream_gene_variant | 1 | NM_001379610.1 | ENSP00000296695.5 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152216Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
24
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000185 AC: 252AN: 1364074Hom.: 0 Cov.: 30 AF XY: 0.000185 AC XY: 124AN XY: 671976
GnomAD4 exome
AF:
AC:
252
AN:
1364074
Hom.:
Cov.:
30
AF XY:
AC XY:
124
AN XY:
671976
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000158 AC: 24AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74490
GnomAD4 genome
AF:
AC:
24
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary pancreatitis Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this non-coding change disrupts SPINK1 protein function (PMID: 21610753, 28556356, 25792561). This variant has been observed in individuals affected with pancreatitis (PMID: 17003641, 21610753). ClinVar contains an entry for this variant (Variation ID: 239502). This variant is not present in population databases (ExAC no frequency). This variant occurs in a non-coding region of the SPINK1 gene. It does not change the encoded amino acid sequence of the SPINK1 protein. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 25, 2021 | The c.-142T>C variant is located in the 5' untranslated region (5’ UTR) of the SPINK1 gene. This variant results from a T to C substitution 142 bases upstream from the first translated codon. This nucleotide position is well conserved in available vertebrate species. The variant has been detected in multiple individuals with pancreatitis (Keiles S et al. Pancreas, 2006 Oct;33:221-7; Boulling A et al. Eur. J. Hum. Genet., 2011 Oct;19:1066-73). Functional studies showed that this alteration disrupts a putative HNF1-binding site and reduces the SPINK1 promoter activity (Boulling A et al. Eur. J. Hum. Genet., 2011 Oct;19:1066-73; Derikx MH et al. Am. J. Physiol. Gastrointest. Liver Physiol., 2015 May;308:G779-84). However, it is unknown whether the reduced promoter activity is sufficient to cause disease. In addition, the variant has been detected in multiple unaffected individuals at our laboratory. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Tropical pancreatitis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 29, 2023 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 24, 2023 | The SPINK1 c.-142T>C variant (rs755968566) is reported in individuals with chronic pancreatitis and absent from control individuals (Boulling 2011, Derikx 2015, Keiles 2006). This variant is also reported in ClinVar (Variation ID: 239502). Functional characterization shows this variant causes a decrease in promoter activity (Boulling 2011, Derikx 2015). This variant is found in the general population with an overall allele frequency of 0.02% (5/31408 alleles) in the Genome Aggregation Database. The c.-142T>C variant was predicted to disrupt the putative HNF1-binding sequence, and in vitro cross-competition and super shift assays support this prediction (Boulling 2011). However, due to limited information, the clinical significance of this variant is uncertain at this time. References: Boulling A et al. Assessing the pathological relevance of SPINK1 promoter variants. Eur J Hum Genet. 2011 Oct;19(10):1066-73. PMID: 21610753 Derikx MHM et al. Functional significance of SPINK1 promoter variants in chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2015 May 1;308(9):G779-84. PMID: 25792561 Keiles S et al. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas. 2006 Oct;33(3):221-7. PMID: 17003641 - |
SPINK1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 21, 2024 | The SPINK1 c.-142T>C variant is located in the 5' untranslated region. This variant has been reported in the heterozygous state in individuals with chronic pancreatitis (Keiles et al 2006. PubMed ID: 17003641; Boulling et al. 2011. PubMed ID: 21610753). Functional studies suggest the c.-142T>C variant disrupts HNF1 transcription factor binding which results in decreased SPINK1 expression (Boulling et al. 2011. PubMed ID: 21610753; Derikx et al. 2015. PubMed ID: 25792561). This variant is reported in 0.032% of alleles in individuals of European (Non-Finnish) descent in gnomAD. SPINK1 exhibits complicated inheritance in which autosomal recessive and dominant inheritance (with reduced penetrance) have been observed in patients with chronic pancreatitis, as well as possible digenic inheritance with other genes associated with chronic pancreatitis (eg. CFTC, CFTR, PRSS1 see Zou. 2018. PubMed ID: 30420730). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at